AIF1 and cancer: Together, these observations suggest that the differential fluorescence localization in the absence or presence of AIF-1 (diffuse vs. concentrated in the nuclear region) may be directly related to the marked accumulation of doxorubicin when used with AIF-1, which in turn might lead to an increase in doxorubicin’s anti-cancer effect.